Christopher Cornell, Ph.D. US Medical Affairs at Geron Corporation......

[kmall]

Christopher Cornell, Ph.D. - Sr. Field Medical Liaison, Geron Corporation

Hired - August 2022

7/21/2022 - FOSTER CITY, Calif.- Geron Corporation (Nasdaq: GERN) reported that it has granted non-statutory stock options to purchase an aggregate of 405,800 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company. Christopher Cornell is one of these employees.

Christopher Cornell's former employers include: Sierra Oncology, Bristol Meyers Squibb, Amgen, GlaxoSmithKline, Allergan, Scripps Research Institute

Christopher Cornell was employed at Sierra Oncology at the time of it's acquisition by GSK:
https://www.fiercebiotech.com/biotech/s ... ut-came-be

There have been multiple newly hired employees who have migrated to Geron from mid-sized Pharma/Biotech which were recently acquired by Big Pharma. Add Mr Cornell to that list.....which I will provide in the very near future. Is Geron next?

Geron continues to exponentially build out a team for commercialization. These have all been well seasoned top tier candidates. That's pretty much all you need to know. -Kmall

[rccola335]

thanks for all your handwork Kmall

[biopearl123]

Ditto. Kmall’s work has given us the best window we have into Geron’s future direction, plans and potential value. Many thanks. bp

[KTArsenal]

I also would like to say thank you to Kmall.

So, thank you, good sir.

[kmall]

To the 3 replies below, you are all more than welcome. I've always wanted to know the names and backgrounds associated with the employee base here, especially the latest hires post JNJ "discontinuation" that we have continually seen inducement grant PR's for.

We've all heard the expression of "follow the money."

Well I believe in follow the employees as well.

In the case of Geron, it speaks volumes.

Since the hiring of Damanjit Singh – Associate Director Quality Assurance – who was hired in November 2018, the first known employee added post JNJ non-discontinuation, specializing in GXP Quality Systems - a GXP Quality Systems Specialist is an essential employee for the Regulatory Approval and commercialization process of a drug undergoing Clinical Trials.....

To Dr. Aleksandra Rizo joining Geron as CMO and who was the Senior Director, Compound Development Team Leader at Janssen for the Imetelstat program during the Janssen/Geron collaboration 2014-2018, prior to joining Geron..........

To Nishan Sengupta - VP, Market-Access, Pricing, Evidence Strategy, Geron Corporation, hired in August 2021 and is currently also employed at JNJ as Global/US Access Strategy Lead-IMBRUVICA, B-Cell, Rare Hematology........(conflict of interest or continuation from the "discontinuation" ????.......more questions than answers here if you ask me)..........

The backgrounds of these latest hires is exemplary. These employees are top tier, "cream of the crop" if you will. They could work anywhere.

Almost all of these latest hires have come from Big Pharma, in secure positions.

A good many have come directly from Big Pharma acquisitions.

Three of these latest hires:

Susan Finan – Employee Benefits – 2021
Dave Clark – CPA, Corporate Controller - 2022
Katherine Harmon, CPA, Assistant Controller - 2022.....

migrated directly from Immunomedics, which was acquired by Gilead for $21B in 2020.

https://www.gilead.com/news-and-press/p ... medics-inc

I believe as Andrew-bp so eloquently put it, looking at the Geron employee structure gives us the "best window we have into Geron’s future direction, plans and potential value."

Stay tuned, more of Geron's latest hires to come. -Kmall

[kmall]

Known current Geron Employees as of 8/26/2022 and their initial hiring dates –
* Former Janssen employee
+ Part-time or Consultant

Management:
1 - CEO – Dr. John A. Scarlett, MD - 2011
2 - CFO – Olivia K. Bloom - 1994
3 - CAO – Melissa A. Kelly Behrs – 1998
4. – CBO – Edward Koval - 2021
5 - COO – Andrew J. Grethlein - 2012
6 - CCO* – Anil Kapur - 2019
7 - CMO* – Faye Feller, MD - 2019
8 - CLO – Stephen N. Rosenfield - 2011

Clinical – Operations, Science, Development:
Faye Feller*(7), MD – CMO – 2019
9 - Laurie Sherman* – VP Clinical Operations – 2019
10 - Souria Dougherty* - Ex Director Clinical Science - 2019
11 - Tymara Berry – Ex Director Clinical Development - 2020
12 - Sheetal Shah – Sr Director – 2020
13 - Denise Redding – Director - 2021
14 - Jeff Ryel – Director Clinical Operations - 2020
15 - Karie Arnold – Director Clinical Operations –
2021
16 - Brandie Jonas – Director Program Management – 2019
17 - F Matthew Bakthasekaran - Sr Manger, Clinical Program Management - 2022
18 - Judy Ho - Sr Manager - 2022
19 - Natasha M - Associate Director, Clinical Research - 2021
20 - Kate Turner - Associate Director Clinical Operations - 2022
21 – Carolina Jacobs – Sr Project Manager - 2012
22 - Daria Zielinska – Sr Scientist – 2001
23 - Ron Pruzan – Principal Scientist – 2010
24 – Yelena Polonskaya – Sr Research Associate - 2001
25 - Barbara Mandelkow (Germany) Lab Assistant - 2017
26 - Janet Ahern(+) - Clinical Research Consultant - 2022
27 - Dr. Aleksandra Rizo*(+) - Sr. Medical and Regulatory Advisor - 2019
(currently employed at Vividion and Geron)
28 - Mebratu Gebreyesus(+) - Sr Development Associate - 2010
(currently employed at Bayer, Celltheon and Geron)
29 - Kerry Mundt(+) – CT Assistant – 2010
(currently employed by Pharmacyclics/Abbvie and Geron)

Pharmacovigilance and Drug Safety/Information:
30 - Patti N. – Ex Director Drug Safety – 2020
31 – Annat Ikin - Director Medical Writing – 2021

Business Development:
Melissa A. Kelly Behrs (3) – Chief Alliance Officer – 2014
Edward Koval (4) – CBO - 2021
Anil Kapur* (6) - COO - 2019
32 - Jason Grossman - Ex Director, Commercial Operations - 2022
33 - Nishan Sengupta - VP, Market-Access, Pricing, Evidence Strategy (+) - 2021
(currently employed at JNJ and Geron)
34 - Denise Meyer – VP Medical Affairs – 2021
35 - Christopher Cornell - Sr. Field Medical Liaison - 2022
36 - Helen Lee – Sr. Reporting Analyst - 2012
37 - Anthony Kuczynski – Analyst - 2019
38 - Aron Feingold - VP Investor Relations & Corporate Communication - 2022

Finance:
Olivia K. Bloom (2) – CFO – 1994
39 - Karen Boyce – VP -2008
40 - Andrew Good – Ex Director – 2006
41 - Gilian Fong – Director – 2021
42 – Iasko Cable – Sr. Clinical Trial Accountant – 2019
43 – Dave Clark – CPA, Corporate Controller - 2022
44 - Katherine Harmon, CPA, Assistant Controller - 2022

Data Management:
45 - Ben Thorp - Head of Clinical Data Management - 2022
46 - Rana F.* – Director, Statistical Programming - 2020
47 - Sridevi Sridhar, CCDM – Associate Director – 2021

Manufacturing:
48 - Patrick Murphy – VP Manufacturing – 2019
49 - Eric Mueller – Director – 2019
50 - Leslie C. – CMC Director - 2021
51 - Bharat Baral* – CMC Manager – 2021 & 2011
52 - William Garzon-Rodriguez* - Associate Director Drug Product Manufacturing – 2021
53 - Tim Tickner – Director, Supply Chain Management – 2022

Regulatory:
54 - Sharon McBain* - VP Global - 2019
55 - Shirin Mirshamsi* – Director EU – 2019
56 - Ilesh Sanathra* - Director Global – 2020
57 - Nick Lyon – Director – 2020
58 – Ronan Balicanta* Senior Manager, Submissions - 2022
59 - Tarin Araujo - Senior Manager US - 2022

Biostatistics:
60 - Ying Wan* – VP - 2019
61 - Libo Sun* – Director - 2019

Quality Assurance and Quality Control:
62 - Denise Grippo – VP Quality and Compliance – 2019
63 - Samantha Taylor – QA Manager, Document Control – 2007
64 - Joe Denton – Director – 2019
65 - Damanjit Singh – Sr Manager – 2018
66 - Willie Mobley – Materials/Document Specialist - 2007
67 - Leah Wood – Manager – 2021
68 - Murugappa Vedachalam (+) – QA/QC/CMC Consultant - 2019

Legal and Intellectual Property:
Stephen L. Rosenfield (8) – CLO – 2011
69 - Pamela Smith – Associate General Counsel - 1999
70 - Christopher Johnson – Director - 2019
71 - Laura Reederson – Director - 2020
72 - Leslie Mooi – VP IP – 2007
73 - Abby B. – Sr Patent Paralegal - 2014
74 - Cheryl Northern – Sr. Contracts Manager – 2007
75 – Brittney Hernandez – Contracts Manager – 2021

Facilities Operations and Information Technology:
76 - Michael Yamada – VP -2007
77 - Jyoti Shetty – Sr Director IT – 2021
78 - John Albert - Director Information Technology Infrastructure - 2022
79 - Miguel Hundelt – Systems Administrator – 2018
80 – Julian Cornejo - Systems Administrator - 2021
81 - Briana Martinez – Ex Assistant - 2006
82 - Julia Mensing – Ex Assistant – 2011
83 - Stacie W. – Ex Assistant - 2020
84 - Mia Pham – Office Manager - 2020

Human Resources:
85 - Shannon Odam – HR Executive -2019
86 - Stephanie Dellari – Director - 2004
87 - Susan Finan – Employee Benefits – 2021
88 - Marisa Cerniglia - Manager, People Operations – 2021
89 – Jennifer Allen - Associate Director, Talent Acquisition – 2022
90 – Fiona McAuliffe – Talent Acquisition Associate - 2022

**This latest "known" Geron employee roster reflects the most recent additions of:

19 - Natasha M - Associate Director, Clinical Research
35 - Christopher Cornell - Sr. Field Medical Liaison